Effectiveness of atypical antipsychotics for substance use in schizophrenia patients

Jeffrey Swanson; Richard Van Dorn; Marvin Swartz

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Accept

Effectiveness of atypical antipsychotics for substance use in schizophrenia patients

Swanson, J., Van Dorn, R., & Swartz, M. (2007). Effectiveness of atypical antipsychotics for substance use in schizophrenia patients. Schizophrenia Research, 94, 114 - 118.

Copy citation

Recent Publications

Article

Multifaceted risk for non-suicidal self-injury only versus suicide attempt in a population-based cohort of adults

Article

Long-term effects of a diet supplement containing Cannabis sativa oil and Boswellia serrata in dogs with osteoarthritis following physiotherapy treatments

Article

Epigenetic biomarkers for smoking cessation

Article

Effectiveness of atypical antipsychotics for substance use in schizophrenia patients

Publications Info

Recent Publications

Multifaceted risk for non-suicidal self-injury only versus suicide attempt in a population-based cohort of adults

Long-term effects of a diet supplement containing Cannabis sativa oil and Boswellia serrata in dogs with osteoarthritis following physiotherapy treatments

Epigenetic biomarkers for smoking cessation

A pilot PT scheme for external assessment of laboratory performance in testing synthetic opioid compounds in urine, plasma, and whole blood

Partner With Us

Site